RGLS
Regulus Therapeutics Inc.
10% owner Scott D Sandell bought $2.7M of Regulus Therapeutics Inc.
Bought$2,735,930
$0.62Price
4,398,602Shares
+214%Stake
What RGLS did for a copier
Prices for RGLS after this filing aren't in yet.
Scott D Sandell's record
6 other buys with 3 months of prices since 2016: on average −6.6% against the S&P 500, and 2 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Dec 4. Filed Mon, Dec 7, 12:12 PM ET, during the session. Not investment advice.